Guía de práctica clínica para el manejo sindrómico de los pacientes con infecciones de transmisión sexual y otras infecciones del tracto genital - 2013

  • Hernando Guillermo Gaitán-Duarte
  • Andrea Esperanza Rodríguez-Hernández
  • Ingrid Arévalo-Rodriguez
  • Edith Ángel-Müller
  • Hugo Enrique López-Ramos
  • Jesús Santiago Estrada-Mesa
  • Colaboradores Grupo Desarrollador de la de manejo sindrómico ITS y otras ITG

Resumen

Objetivo: reducir la variabilidad de la práctica en el manejo de las infecciones del tracto genital y de las infecciones de transmisión sexual; apoyar a los profesionales de la salud que atienden pacientes con ITG/ITS, con la más reciente evidencia respecto a la efectividad y seguridad de las intervenciones para la prevención primaria, secundaria y terciaria, y generar indicadores de implementación de la guía y de su impacto en la salud pública.

Materiales y métodos: se constituyó un equipo desarrollador en el que participaron diferentes profesionales de la salud y representantes de pacientes. Se formularon preguntas clínicas relevantes y se realizó una búsqueda en repositorios nacionales e internacionales de Guías. Se evaluaron las Guías disponibles en cuanto a su calidad y aplicabilidad. Dado que ninguna guía cumplió con los criterios de adaptación, se decidió el desarrollo de una Guía de Novo. Se realizó una búsqueda de revisiones sistemáticas y metaanálisis, ensayos clínicos y estudios observacionales en las bases de datos pubmed, ovid, embase, cochrane y lilacs. Se elaboraron las tablas de evidencia y las recomendaciones con la aproximación grade por metodología de consenso formal e informal.

Resultados: se presenta la “Guía de práctica clínica” con las recomendaciones y la evidencia de soporte para la prevención, el diagnóstico, tratamiento en cuanto a efectividad y seguridad, y seguimiento de los síndromes de: cervicitis, uretritis, úlcera genital, flujo vaginal, inflamación escrotal y bubón inguinal.

Conclusiones: como recomendación central de implementación se plantea el manejo del paciente por medio de la dosis única y tratamiento expedito del compañero cuando sea posible. La Guía deberá actualizarse en tres años.

Biografía del autor/a

Hernando Guillermo Gaitán-Duarte
Especialista en Obstetricia y Ginecología. MSc en Epidemiología Clínica. Profesor Titular, Departamento de Obstetricia y Ginecología e Instituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia. Coordinador editorial Grupo Cochrane de Infecciones de Transmisión Sexual. Bogotá, Colombia. Líder de la Guía.
Andrea Esperanza Rodríguez-Hernández
Médica cirujana. Especialista en Estadística Aplicada. Magíster en Epidemiología Clínica. Docente auxiliar de posgrado, Instituto de Investigaciones Clínicas, Universidad Nacional de Colombia. Coordinadora Metodológica de la Guía. Bogotá, Colombia.
Ingrid Arévalo-Rodriguez
Psicóloga. Magíster en Epidemiología Clínica, Universidad Nacional de Colombia. PhD (c) en Pediatría, Obstetricia y Ginecología, Medicina Preventiva y Salud Pública, Universidad Autónoma de Barcelona. Bogotá, Colombia.
Edith Ángel-Müller
Médica cirujana. Especialista en Obstetricia y Ginecología. Fellow en Infectología Ginecoobstétrica y Perinatal. Profesora Asociada Departamento de Obstetricia y Ginecología, Universidad Nacional de Colombia. Representante de la Federación Colombiana de Obstetricia y Ginecología. Miembro Comité Editorial Grupo Cochrane de Infecciones de Transmisión Sexual. Bogotá, Colombia.
Hugo Enrique López-Ramos
Médico cirujano. Especialista en Urología. Candidato a magíster en Epidemiología Clínica. Miembro de Número de la Sociedad Colombiana de Urología. Representante de la Sociedad Colombiana de Urología en la elaboración de la Guía. Bogotá, Colombia.
Jesús Santiago Estrada-Mesa
Médico cirujano. Especialista en Microbiología y Parasitología Médica. Director general Laboratorio Clínico Congregación Mariana, Fundación Santa María, Medellín, Colombia. Representante de la Asociación Colombiana de Infectología (ACIN). Medellin, Colombia.
Colaboradores Grupo Desarrollador de la de manejo sindrómico ITS y otras ITG
Colaboradores Grupo Desarrollador de la Guía de manejo sindrómico ITS y otras ITG

Citas

Ministerio de Salud República de Colombia Resolución Número 412 de 2000.

OMS. Infecciones de trasmisión sexual y otras infecciones del tracto reproductivo. Una guía para la practica básica; 2005.

Ángel-Müller E, González MP, Núñez L, Pacheco J, Tolosa J E, Díaz LA, et al. Frecuencia de infecciones del tracto genital femenino en mujeres sintomáticas y uso de pruebas rápidas para su diagnóstico en dos poblaciones de Bogotá (Colombia) 2008: Estudio piloto. Rev Colomb Obstet Ginecol. 2010;61:220-30.

Workowski KA, Berman S. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 2010;59:1-110.

Angel-Müller E, Rodriguez A, Nuñez- Forero L, Moyano Bohórquez LF, González MP, Osorio E, et al. Prevalencia de C. trachomatis, N. gonorrheae, T. Vaginalis, C. albicans, sífilis y Vaginosis bacteriana en mujeres con síntomas de infección vaginal en Bogotá, Colombia 2010. Rev Colomb Obstet Ginecol. 2012;63:14-24.

European STD guidelines European Branch of the International Union against Sexually Transmitted Infection and the European Office of the World Health Organization Int J STD AIDS. 2001;12(Suppl 3):1-94.

Eckert LO. Acute Vulvovaginitis. N Engl J Med. 2006;21:1244-52.

Guías para el tratamiento de las infecciones de transmisión sexual. Organización Mundial de la Salud; 2005 [visitado 2012 feb 15]. Disponible en: http://whqlibdoc.who.int/publications/2005/9243592653_spa.pdf

Canadian Guidelines on Sexually Transmitted Infections. Ottawa: Public Health Agency of Canada; 2010.

Gaitan H, Angel E, Diaz R, Parada A, Sanchez L, Vargas C. Accuracy of five different diagnostic techniques in mild-to-moderate pelvic inflammatory disease. Infect Dis Obstet Gynecol. 2002;10:171-80.

UnAIDS/WHO. Sexually transmitted diseases: policies and principles for prevention and care. UnAIDS Best Practice Collection Key Material Geneva: UnAIDS/ WHO; 1999.

Acosta JP, Rodriguez DCR. Situación de las infecciones de transmisión sexual, Colombia,1976-2000. Biomédica. 2002;22:77- 88.

Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol. 2000;19:1-5.

Trei JS, Canas LC, Gould PL. Reproductive tract complications associated with Chlamydia trachomatis infection in US Air Force males within 4 years of testing. Sex Transm Dis. 2008;35:827-33.

Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines 3: rating the quality of evidence - introduction. J Clin Epidemiol. 2011;64:401-6.

Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, Schünemann HJ, GRADE Working Group. Going from evidence to recommendations. BMJ. 2008;336:1049-51.

Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, Gopal R, Ojwiya A. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet. 2003;36:645-52.

Grosskurth HMF, Todd J, Mwijarubi E, Klokke A, Senkoro K, Mayaud P, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995;346:530-6.

Ng B, Butler L, Horvath T, Rutherford G. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection. Cochrane Database of Systematic Reviews. 2011(Issue 3. Art. No.: CD001220. DOI:10.1002/14651858.CD001220.pub3).

NIAID. Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. 2001 Disponible en: www.niaid.nih.gov/about/organization/dmid/documents/condomreport.pdf.

Macaluso M, Blackwell R, Jamieson D. Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial. Am J Epidemiol. 2007:88-96.

Wilkinson DRG, Tholandi M, Rutherford GW. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men. Cochrane Database of Systematic Reviews. 2002 (Issue 1. Art. No.: CD003939. DOI:10.1002/14651858.CD003939.).

Camejo MDM. Prevalencia de hepatitis B, hepatitis C y sífilis en trabajadoras sexuales de Venezuela / Prevalence of hepatitis B, hepatitis C and syphilis in female sex workers in Venezuela. Rev saúde pública. 2003;37:339-44.

Chin H, Sipe TA, Elder R, Mercer SL, Chattopadhyay SK, Jacob V, et al. Community Preventive Services Task Force. The effectiveness of group-based comprehensive risk-reduction and abstinence education interventions to prevent or reduce the risk of adolescent pregnancy, human immunodeficiency virus, and sexually transmitted infections: two systematic reviews for the Guide to Community Preventive Services. Am J Prev Med. 2012;42:272-94.

Baeten JM, Nyange PM, Richardson BA, Lavreys L, Chohan B, Martin HL, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study. Am J Obstet Gynecol. 2001;185:380-5.

Beigi RH, Meyn LA, Moore DM, Krohn Ma, Hillier SL. Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet Gynecol. 2004;104:926-30.

Cherpes TL, Meyn La, Krohn Ma, Lurie JG, Hillier SL. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis. 2003;37:319-25.

Crosby Ra, DiClemente RJ, Wingood GM, Salazar LF, Rose E, Levine D, et al. Associations Between Sexually Transmitted Disease Diagnosis and Subsequent Sexual Risk and Sexually Transmitted Disease Incidence Among Adolescents. Sex Transm Dis. 2004;31:205-8.

DiClemente RJ, Crosby RA, Wingood GM, Lang DL, Salazar LF, Broadwell SD. Reducing risk exposures to zero and not having multiple partners: findings that inform evidence-based practices designed to prevent STD acquisition. International journal of STD & AIDS. 2005;16:816-8.

Ford CA, Pence BW, Miller WC, Resnick MD. Predicting Adolescents' Longitudinal Risk for Sexually Transmitted Infection. Archives of Pediatrics. 2005;159:657-64.

Fortenberry JD, Brizendine EJ, Katz BP, Wools KK, Blythe MJ, Orr DP. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis. Sex Transm Dis. 1999;26:26-32.

Gallo MF, Warner L, Macaluso M, Stone KM, Brill I, Fleenor ME, et al. Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic. Sex Transm Dis. 2008;35:679-85.

Helms DJ, Mosure DJ, Metcalf Ca, Douglas JM, Malotte CK, Paul SM, et al. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics. Sex Transm Dis. 2008;35:484-8.

Niccolai LM, Kopicko JJ, Kassie A, Petros H, Clark RA, Kissinger P. Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women. Sex Transm Dis. 2000;27:284-8.

Moss NJ, Harper CC, Ahrens K, Scott K, Kao S, Padian N, et al. Predictors of incident herpes simplex virus type 2 infections in young women at risk for unintended pregnancy in San Francisco. BMC Infect Dis. 2007;7:113.

Fleming DT, Levine WC, Trees DL, Tambe P, Toomey K, St Louis ME. Syphilis in Atlanta during an era of declining incidence. Sex Transm Dis. 2000;27:68-73.

Gottlieb SL, Douglas JM, Foster M, Schmid DS, Newman DR, Baron AE, et al. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. The Journal of infectious diseases. 2004;190:1059-67.

Ko NY, Liu HY, Lee HC, Lai YY, Chang CM, Lee NY, et al. One-year follow-up of relapse to risky behaviors and incidence of syphilis among patients enrolled in the HIV case management program. AIDS and behavior. 2011;15:1067-74.

Thurnheer MC, Weber R, Toutous-Trellu L, Cavassini M, Elzi L, Schmid P, et al. Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study. AIDS (London, England). 2010;24:1907-16.

Rich JD, Hou JC, Charuvastra A, Towe CW, Lally M, Spaulding A, et al. Risk factors for syphilis among incarcerated women in Rhode Island. AIDS Patient Care STDS. 2001;15:581-5.

Todd J, Munguti K, Grosskurth H, Mngara J, Changalucha J, Mayaud P, et al. Risk factors for active syphilis and TPHA seroconversion in a rural African population. Sexually transmitted infections. 2001;77:37-45.

Xu J-J, Zhang M, Brown K, Reilly K, Wang H, Hu Q, et al. Syphilis and HIV seroconversion among a 12-month prospective cohort of men who have sex with men in Shenyang, China. Sexually transmitted diseases. 2010;37:432-9.

Sahlu T, de Wit TR, Tsegaye a, Mekonnen Y, Beyene A, Hailu B, et al. Low incidence of syphilis among factory workers in Ethiopia: effect of an intervention based on education and counselling. Sexually transmitted infections. 2002;78:123-6.

Zhou H, Chen XS, Hong FC, Pan P, Yang F, Cai YM, et al. Risk factors for syphilis infection among pregnant women: results of a case-control study in Shenzhen, China. Sexually transmitted infections. 2007;83:476-80.

Radcliffe KW, Ahmad S, Gilleran G, Ross JD. Demographic and behavioural profile of adults infected with chlamydia: a case-control study. Sexually transmitted infections. 2001;77:265-70.

Ferreira A, Young T, Mathews C, Zunza M, Low N. Strategies for partner notification for sexually transmitted infections, including HIV. Cochrane Database of Systematic Reviews; 2013. Pub ahead of print.

Bignell C, Fitzgerald M, Group GD, UK BAfSHaH. UK national guideline for the management of gonorrhoea in adults, 2011. Int J STD AIDS. 2011;22:541-7.

Carey AJ, Beagley KW. Chlamydia trachomatis, a hidden epidemic: effects on female reproduction and options for treatment. Am J Reprod Immunol. 2010;63:576-86.

Tolosa JE, Rodríguez AE, Müller EA, Ruiz-Parra AI, Núñez-forero L, Moyano LF, Gaitán-Duarte H. Accuracy of syndromic diagnosis and management of vaginal discharge and cervicitis in women of reproductive age in Bogotá, Colombia. Int J Gynecol Obstet. 2012;119(S3):S729. BN00207292.

Núñez-Forero, Moyano LF, Angel-Müller E, Rodríguez A, Ruiz-Parra AI, Tolosa JE, Gaitán-Duarte H. Diagnostic accuracy of rapid tests for C. Trachomatis, N. Gonorrhoeae and Syphilis at the point of care in women with symptoms of lower genital tract infection Int J Gynecol Obstet. 2012;119(S3):S350.

Van der Helm JJ, Sabajo LO, Grunberg AW, Morré SA, Speksnijder AG, de Vries HJ. Point-of-care test for detection of urogenital chlamydia in women shows low sensitivity. A performance evaluation study in two clinics in Suriname. PLoS One. 2012;7:e32122. doi: 10.1371/journal.pone.0032122.

Van Dommelen L, van Tiel FH, Ouburg S, Brouwers EE, Terporten PH, Savelkoul PH, Morré SA, Bruggeman CA, Hoebe CJ. Alarmingly poor performance in Chlamydia trachomatis point-of-care testing. Sex Transm Infect. 2010;86:355-9.

Yin YP, Peeling RW, Chen XS, Gong KL, Zhou H, Gu WM, et al. Clinic-based evaluation of Clearview Chlamydia MF for detection of Chlamydia trachomatis in vaginal and cervical specimens from women at high risk in China. Sex Transm Infect. 2006;82:v33-7.

Díaz-Rojas J, García-Molina M, Chicaíza-Becerra L, Moreno-Calderón A, Prieto- Martínez V, Gaitán-Duarte H, et al. Costo-efectividad del diagnóstico etiológico con pruebas rápidas vs. síndromico en mujeres no gestantes con síntomas de infección cervical. Cuadernos de economía. 2012;39:2-48.

Lau C, Qureshi A. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002;29:497-502.

Sendag F, Terek C, Tuncay G, Ozkinay E, Güven M. Single dose oral azithromycin versus seven day doxycycline in the treatment of non-gonococcal mucopurulent endocervicitis. Aust N Z J Obstet Gynaecol. 2000;40:44-7.

Guven MA, Gunyeli I, Dogan M, Ciragil P, Bakaris S, Gul M. The demographic and behavioural profile of women with cervicitis infected with Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum and the comparison of two medical regimens. Arch Gynecol Obstet. 2005;272:197-200.

Rustomjee R, Kharsany A, Connolly C, Karim S. A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. J Antimicrob Chemother. 2002;49:875-8.

Shams-ur-Rehman, Khan A, Amanullah, Akhter K. Clinical efficacy of the various drugs used in the treatment of gonorrhoeae. J Ayub Med Coll Abbottabad. 2009;21:28-30.

Ness RB, Soper DE, Richter HE, Randall H, Peipert JF, Nelson DB, et al. Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study. Sex Transm Dis. 2008;35:129-35.

Paavonen J. Pelvic inflammatory disease. From diagnosis to prevention. Dermatol Clin. 1998;16:747-56.

Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010;201(Suppl2):S134-55.

Brocklehurst P, Rooney G. Interventions for treating genital Chlamydia trachomatis infection in pregnancy Cochrane Database Syst Rev. 2000;2:CD000054.

Brocklehurst P. Antibiotics for gonorrhoea in pregnancy. Cochrane Database Syst Rev. 2002;2:CD000098.

Cavenee MR, Farris JR, Spalding TR, Barnes DL, Castaneda YS, Wendel GD. Treatment of gonorrhea in pregnancy. Obstet Gynecol. 1993;81:33-8.

Hammerschlag MR. Chlamydial and gonococcal infections in infants and children. Clin Infect Dis. 2011;53(Suppl 3):S99-102.

de Barbeyrac B, Papaxanthos-Roche A, Mathieu C, Germain C, Brun JL, Gachet M, et al. Chlamydia trachomatis in subfertile couples undergoing an in vitro fertilization program: a prospective study. Eur J Obstet Gynecol Reprod Biol. 2006;129:46-53.

Carter JD, Espinoza LR, Inman RD, Sneed KB, Ricca LR, Vasey FB, et al. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum. 2010;62:1298-307.

OMS Módulos de capacitación para el manejo sindrómico de las infecciones de transmisión sexual. Ginebra OMS: Organización Mundial de la Salud; 2008.

Tucker JD, Bu J, Brown LB, Yin YP, Chen XS, Cohen MS. Accelerating worldwide syphilis screening through rapid testing: a systematic review. Lancet Infect Dis. 2010;10:381-6.

Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. New England Journal of Medicine. 1997;337:307-14.

Bai ZG, Yang KH, Liu YL, Tian JH, Ma B, Mi DH, et al. Azithromycin vs. benzathine penicillin G for early syphilis: a meta-analysis of randomized clinical trials. International journal of STD & AIDS. 2008;19:217-21.

Bai ZG, Wang B, Yang K, Tian JH, Ma B, Liu Y, Jiang L, Gai QY, He X, Li Y. Azithromycin versus penicillin G benzathine for early syphilis. Cochrane Database Syst Rev. 2012;13;6:CD007270.

Moorthy TT, Lee CT, Lim KB, Tan T. Ceftriaxone for treatment of primary syphilis in men: a preliminary study. Sexually transmitted diseases. 1987;116-8.

Wong T, Singh AE, De P. Primary syphilis: serological treatment response to doxycycline/tetracycline versus benzathine penicillin. Am J Med. 2008;121:903-8.

Tyndall MW, Agoki E, Plummer FA, Malisa W, Ndinya-Achola JO, Ronald AR. Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin. Sexually transmitted diseases 1994;21:231-4.

Martin DH, Sargent SJ, Wendel GD, McCormack WM, Spier NA, Johnson RB. Comparison of azithromycin and ceftriaxone for the treatment of chancroid. Clinical Infectious Diseases. 1995;21:409-14.

Malonza IM, Tyndall MW, Ndinya-Achola JO, Maclean I, Omar S, MacDonald KS, et al. A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. The Journal of Infectious Diseases. 1999;180:1886-93.

Greaves AB, Hilleman MR, Taggart SR, Bankhead AB, Feld M. Chemotherapy in bubonic lymphogranuloma venereum: a clinical and serological evaluation. Bull World Health Organ. 1957;16:277-89.

Martin DH, Mroczkowski TF, Dalu ZA, McCarty J, Jones RB, Hopkins SJ, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. The New England journal of medicine [Clinical Trial. Comparative Study. Multicenter Study. Randomized Controlled Trial. 1992;327:921-5.

Thorpe EM, Jr., Stamm WE, Hook EW, 3rd, Gall SA, Jones RB, Henry K, et al. Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises. Genitourin Med. 1996;72:93-7.

Banov L, Jr. Rectal strictures of lymphogranuloma venereum; some observations from a five-year study of treatment with the broad spectrum antibiotics. Am J Surg. 1954;88:761-7.

Greenblatt RB, Barfield WE, Dienst RB, West RM. Terramycin in treatment of granuloma inguinale. J Vener Dis Inf. 1951;32:113-5.

Robinson HM, Jr., Cohen MM. Treatment of granuloma inguinale with erythromycin. J Invest Dermatol. 1953;20:407-9.

Bowden M, Plunkett, & Bastian. Pilot study of azithromycin in the treatment of genital donovanosis. Genitourin Med. 1996;72:17-9.

Bryson YJ, Dillon M, Lovett M. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. New England Journal of Medicine. 1983;308:916-21.

Mertz GJ, Critchlow CW, Benedetti J. Double-blind placebo-controlled trial or oral acyclovir in first-episode genital herpes simplex virus infection. Journal of the American Medical Association. 1984;252:1147-51.

Nilsen AE, Aasen T, Halsos AM, Kinge BR, Tjotta EA, Wikstrom K, et al. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet. 1982 ;2:571-3.

Fife KH, Barbarash RA, Rudolph T, Degregorio B, Roth R. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group. Sex Transm Dis. 1997;24:481-6.

Lebrun-Vignes B, Bouzamondo A, Dupuy A, Guillaume JC, Lechat P, Chosidow O. A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks. Journal of the American Academy of Dermatology. 2007;57:238-46.

French P. Syphilis. Bmj. 2007;334:143-7.

Eccleston K, Collins L, Higgins SP. Primary syphilis. International journal of STD & AIDS. 2008;19:145-51.

Gupta R, Warren T, Wald A. Genital herpes. Lancet. 2007;370:2127-37.

Lewis DA. Chancroid: clinical manifestations, diagnosis, and management. Sex Transm Infect. 2003;79:68-71.

Mabey D, Peeling RW. Lymphogranuloma venereum. Sex Transm Infect. 2002;78:90-2.

Blencowe H, Cousens S, Kamb M, Berman S, Lawn JE. Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Public Health. 2011;11(Suppl3):S9.

Walker GJ. Antibiotics for syphilis diagnosed during pregnancy. Cochrane Database Syst Rev. 2001:CD001143.

Wendel GD, Sheffield JS, Hollier LM, Hill JB, Ramsey PS, Sanchez PJ. Treatment of syphilis in pregnancy and prevention of congenital syphilis. Clin Infect Dis. 2002;35(Suppl 2):S200-9.

Walker GJ, Walker DG. Congenital syphilis: a continuing but neglected problem. Semin Fetal Neonatal Med. 2007;12:198-206.

Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997;337:509-15.

Lowe NK, Neal JL, Ryan-Wenger NA. Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard. Obstet Gynecol. 2009;113:89-95.

Pépin J, Sobela F, Khonde N, Agyarko-Poku T, Diakité S, Deslandes S, et al. The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa. Bull World Health Organ. 2006;84:729-38.

Oduyebo OO Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev. 2009:CD006055.

Bohbot JM, Vicaut E, Fagnen D, Brauman M. Treatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomised phase III study comparing secnidazole and metronidazole. Infect Dis Obstet Gynecol. 2010. 2010. pii: 705692. doi: 10.1155/2010/705692

Forna FGA. Interventions for treating trichomoniasis in women. Cochrane Database of Systematic Reviews; 2003.

Nurbhai MGJ, Watson M, Bond CM, Mollison JA, Ludbrook A. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis(thrush). Cochrane Database of Systematic Reviews; 2007.

Kanno M, Sobel JD. Late recurrence of resistant Trichomonas vaginalis vaginitis: relapse or re-infection? Sex Transm Infect. 2003;79:260-1.

Hager WD. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients. Sex Transm Dis. 2004;31:343-5.

Saporiti AM, Gomez D, Levalle S, Galeano M, Davel G, Vivot W, et al. Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use. Rev Argent Microbiol. 2001;33:217-22.

Sobel JD, Ferris D, Schwebke J, Nyirjesy P, Wiesenfeld HC, Peipert J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006;194:1283-9.

Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351:876-83.

Roth AC, Milsom I, Forssman L, Wahlén P. Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet. Genitourin Med. 1990;66:357-60.

Lyng J, Christensen J. A double-blind study of the value of treatment with a single dose tinidazole of partners to females with trichomoniasis. Acta Obstet Gynecol Scand. 1981;60:199-201.

Calderón-Márquez JJ. Itraconazole in the treatment of vaginal candidosis and the effect of treatment of the sexual partner. Rev Infect Dis. 1987;9(Suppl1):S143-5.

Mehta SD. Systematic review of randomized trials of treatment of male sexual partners for improved bacteria vaginosis outcomes in women. Sex Transm Dis. 2012;39:822-30.

McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2007:CD000262.

Lamont R, Nhan-Chang C, Sobel J, Workowski K, Conde-Agudelo A, Romero R. Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011;205:177-90.

Gulmezoglu AM, Azhar M. Interventions for trichomoniasis in pregnancy. Cochrane Database Syst Rev. 2011:CD000220.

Caro-Paton T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodriguez Pinilla E. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol. 1997;44:179-82.

Young GL, Jewell D. Topical treatment for vaginal candidiasis (thrush) in pregnancy. Cochrane Database Syst Rev. 2001:CD000225.

Cotch MF, Pastorek JG, Nugent RP, Hillier SL, Gibbs RS, Martin DH, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 1997;24:353-60.

Smith LM, Wang M, Zangwill K, Yeh S. Trichomonas vaginalis infection in a premature newborn. J Perinatol. 2002;22:502-3.

Cotch MF, Hiller SL, Gibbs RS, Eschenbach DA. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. American Journal of Obstetrics and Gynecology. 1998;178:374-80.

Trojian TH, Lishnak TS, Heiman D. Epididymitis and orchitis: an overview. Am Fam Physician. 2009;79:583-7.

Stewart A, Ubee SS, Davies H. Epididymo-orchitis. BMJ. 2011;342:d1543.

Ostaszewska I, Zdrodowska-Stefanow B, Darewicz B, Darewicz J, Badyda J, Pucilo K, et al. Role of Chlamydia trachomatis in epididymitis. Part II: Clinical diagnosis. Med Sci Monit. 2000;6:1119-21.

Kemp M, Christensen JJ, Lautenschlager S, Vall-Mayans M, Moi H. European guideline for the management of chancroid, 2011. Int J STD AIDS. 2011;22:241-4.

Nieuwenhuis RF, Ossewaarde JM, Götz HM, Dees J, Thio HB, Thomeer MG, et al. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis. 2004;39:996-1003.

Mistrangelo M, Conte ID, Gregori G, Castellano I, Famiglietti F, De Vries HJ. Rectal Lymphogranuloma Venereum. Colorectal Dis; 2012.

Bekler C, Kultursay N, Ozacar T, Sayiner A, Yalaz M, Akisu M. Chlamydial infections in term and preterm neonates. Jpn J Infect Dis. 2012;65:1-6.

Publicado
2013-06-30
Sección
Articulo de Revisión